During the past decade, Oxford Eye Hospital conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Oxford Eye Hospital" #1 sponsor was "Apellis Pharmaceuticals, Inc." with 2 trials, followed by "Advanced Vision Science, Inc." with 1 trials sponsored, "Bausch & Lomb Incorporated" with 1 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored and "City, University of London" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Oxford Eye Hospital" #1 collaborator was "Chief Scientist Office of the Scottish Government" with 1 trials as a collaborator, "NHS Grampian" with 1 trials as a collaborator, "Santen Gmbh" with 1 trials as a collaborator and "The European Society of Cataract and Refractive Surgeons(ESCRS)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Oxford Eye Hospital" are "Diabetic Retinopathy" (2 trials), "Retinal Degeneration" (2 trials), "Cataract" (1 trials), "Endophthalmitis" (1 trials) and "Geographic Atrophy" (1 trials). Many other conditions were trialed in "Oxford Eye Hospital" in a lesser frequency.

Most popular intervention types in "Oxford Eye Hospital" are "Drug" (7 trials), "Other" (3 trials), "Procedure" (3 trials), "Combination Product" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "APL-2" (1 trials), "BI 765128" (1 trials), "Cataract surgery" (1 trials) and "Cefuroxime" (1 trials). Other intervention names were less common.

The vast majority of trials in "Oxford Eye Hospital" are 12 trials for "All" genders.

Currently, there are NaN active trials in "Oxford Eye Hospital". undefined are not yet recruiting, 1 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Oxford Eye Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Oxford Eye Hospital, 2 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".